ALPHS — Pharmasimple SA Cashflow Statement
0.000.00%
TechnologyHighly SpeculativeMicro Cap
Annual cashflow statement for Pharmasimple SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2016 December 31st  | 2017 December 31st  | 2018 December 31st  | 2019 December 31st  | 2020 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | — | — | — | 
| Source: | Interim Report | Interim Report | |||
| Standards: | BAS | BAS | — | — | — | 
| Status: | Final | Final | fx Preliminary | fx Preliminary | fx Preliminary | 
| Net Income/Starting Line | -0.941 | -1.37 | — | — | — | 
| Depreciation | |||||
| Changes in Working Capital | -0.765 | -1.85 | — | — | — | 
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.44 | -2.9 | — | — | — | 
| Capital Expenditures | -0.481 | — | — | — | — | 
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0 | — | — | — | 
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.481 | 0 | — | — | — | 
| Financing Cash Flow Items | — | -0.077 | — | — | — | 
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.93 | 5.71 | — | — | — | 
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.013 | 2.81 | — | — | — |